341 related articles for article (PubMed ID: 15221294)
1. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma.
Tharp K; Israel O; Hausmann J; Bettman L; Martin WH; Daitzchman M; Sandler MP; Delbeke D
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1435-42. PubMed ID: 15221294
[TBL] [Abstract][Full Text] [Related]
2. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.
Spanu A; Solinas ME; Chessa F; Sanna D; Nuvoli S; Madeddu G
J Nucl Med; 2009 Feb; 50(2):184-90. PubMed ID: 19164225
[TBL] [Abstract][Full Text] [Related]
3. Incremental value of diagnostic 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma.
Wong KK; Zarzhevsky N; Cahill JM; Frey KA; Avram AM
AJR Am J Roentgenol; 2008 Dec; 191(6):1785-94. PubMed ID: 19020251
[TBL] [Abstract][Full Text] [Related]
4. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.
Chen L; Luo Q; Shen Y; Yu Y; Yuan Z; Lu H; Zhu R
J Nucl Med; 2008 Dec; 49(12):1952-7. PubMed ID: 18997044
[TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma.
Yamamoto Y; Nishiyama Y; Monden T; Matsumura Y; Satoh K; Ohkawa M
J Nucl Med; 2003 Dec; 44(12):1905-10. PubMed ID: 14660715
[TBL] [Abstract][Full Text] [Related]
6. Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma.
Maruoka Y; Abe K; Baba S; Isoda T; Sawamoto H; Tanabe Y; Sasaki M; Honda H
Radiology; 2012 Dec; 265(3):902-9. PubMed ID: 23012466
[TBL] [Abstract][Full Text] [Related]
7. Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation.
Schmidt D; Szikszai A; Linke R; Bautz W; Kuwert T
J Nucl Med; 2009 Jan; 50(1):18-23. PubMed ID: 19091884
[TBL] [Abstract][Full Text] [Related]
8. Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT.
Wong KK; Sisson JC; Koral KF; Frey KA; Avram AM
AJR Am J Roentgenol; 2010 Sep; 195(3):730-6. PubMed ID: 20729453
[TBL] [Abstract][Full Text] [Related]
9. Differentiated thyroid carcinoma: Incremental diagnostic value of
Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
[TBL] [Abstract][Full Text] [Related]
10. Iodine-131 SPET/CT and 18F-FDG PET/CT for the identification and localization of mediastinal lymph node metastases from differentiated thyroid carcinoma.
Xu YH; Shen CT; Xue YL; Qiu ZL; Luo QY
Hell J Nucl Med; 2013; 16(3):199-203. PubMed ID: 24251307
[TBL] [Abstract][Full Text] [Related]
11. The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer.
Grewal RK; Tuttle RM; Fox J; Borkar S; Chou JF; Gonen M; Strauss HW; Larson SM; Schöder H
J Nucl Med; 2010 Sep; 51(9):1361-7. PubMed ID: 20720058
[TBL] [Abstract][Full Text] [Related]
12. Preablation 131-I scans with SPECT/CT in postoperative thyroid cancer patients: what is the impact on staging?
Avram AM; Fig LM; Frey KA; Gross MD; Wong KK
J Clin Endocrinol Metab; 2013 Mar; 98(3):1163-71. PubMed ID: 23430789
[TBL] [Abstract][Full Text] [Related]
13. [Fusion of SPECT with computed tomography or magnetic resonance for the interpretation of abnormal tracer uptake].
Aqueveque A C; González E P; Gutiérrez B D; Jaimovich F R; Díaz P JC; Csendes G P; Orellana P P; Lavados M H; Alliende G I; Araya L S
Rev Med Chil; 2007 Jun; 135(6):725-34. PubMed ID: 17728898
[TBL] [Abstract][Full Text] [Related]
14. Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma.
Ruf J; Lehmkuhl L; Bertram H; Sandrock D; Amthauer H; Humplik B; Ludwig Munz D; Felix R
Nucl Med Commun; 2004 Dec; 25(12):1177-82. PubMed ID: 15640775
[TBL] [Abstract][Full Text] [Related]
15. Utility of Adding SPECT/CT Imaging to Post-Therapeutic Radioiodine Whole-Body Scan in Patients with Differentiated Thyroid Cancer.
Sriprapaporn J; Sethanandha C; Yingsa-nga T; Komoltri C; Thongpraparn T; Harnnanthawiwai C
J Med Assoc Thai; 2015 Jun; 98(6):596-605. PubMed ID: 26219165
[TBL] [Abstract][Full Text] [Related]
16. Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a
Spanu A; Nuvoli S; Marongiu A; Gelo I; Mele L; Piras B; Madeddu G
BMC Cancer; 2020 Mar; 20(1):239. PubMed ID: 32197595
[TBL] [Abstract][Full Text] [Related]
17. High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases.
Ruhlmann M; Jentzen W; Ruhlmann V; Pettinato C; Rossi G; Binse I; Bockisch A; Rosenbaum-Krumme S
J Nucl Med; 2016 Sep; 57(9):1339-42. PubMed ID: 27151981
[TBL] [Abstract][Full Text] [Related]
18. Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECT.
Barwick T; Murray I; Megadmi H; Drake WM; Plowman PN; Akker SA; Chew SL; Grossman AB; Avril N
Eur J Endocrinol; 2010 Jun; 162(6):1131-9. PubMed ID: 20212015
[TBL] [Abstract][Full Text] [Related]
19. Clinical applications of single-photon emission computed tomography/computed tomography in post-ablation
Jiang L; Xiang Y; Huang R; Tian R; Liu B
Pediatr Radiol; 2021 Aug; 51(9):1724-1731. PubMed ID: 33759024
[TBL] [Abstract][Full Text] [Related]
20. 131I SPECT/CT in the follow-up of patients with differentiated thyroid carcinoma.
Menges M; Uder M; Kuwert T; Schmidt D
Clin Nucl Med; 2012 Jun; 37(6):555-60. PubMed ID: 22614186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
